Acadia Scraps a Phase II Alzheimer's Trial, Gets Breakthrough Tag for Dementia-Related Drug

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Acadia Scraps a Phase II Alzheimer's Trial, Gets Breakthrough Tag for Dementia-Related Drug" ALT"Acadia Scraps a Phase II Alzheimer's Trial, Gets Breakthrough Tag for Dementia-Related Drug"October 5, 2017By…

Continue ReadingAcadia Scraps a Phase II Alzheimer's Trial, Gets Breakthrough Tag for Dementia-Related Drug

Johnson & Johnson's Animas to Shut Down Ops and Exit Insulin Pump Biz, 410 Jobs Affected

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-johnson-johnson.jpg" NAME"Johnson & Johnson's Animas to Shut Down Ops and Exit Insulin Pump Biz, 410 Jobs Affected" ALT"Johnson & Johnson's Animas to Shut Down Ops and Exit Insulin Pump…

Continue ReadingJohnson & Johnson's Animas to Shut Down Ops and Exit Insulin Pump Biz, 410 Jobs Affected

Cambridge-Based Biotech Scoops Up $46.7 Million in Funding Round

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Cambridge-Based Biotech Scoops Up $46.7 Million In Funding Round" ALT"Cambridge-Based Biotech Scoops Up $46.7 Million In Funding Round"October 5, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR... Source: BioSpace

Continue ReadingCambridge-Based Biotech Scoops Up $46.7 Million in Funding Round